Skip to main content
    V

    Vaxcyte Inc (PCVX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $61.61
    -1.76 (-2.78%)

    Market Cap: $10.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Vaxcyte Inc (PCVX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Vaxcyte are Abivax SA American Depositary Shares (ABVX), Immunovant (IMVT) and Cytokinetics (CYTK). By market cap, Vaxcyte ranks 3rd of the 13 companies on this page; Exelixis (EXEL) is the largest at $16.84B. The median P/E of the 4 companies with a P/E is 34.1x.

    Peer Comparison

    PCVX's revenue growth of 0.0% is below the peer median of 20.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Vaxcyte (PCVX)$10.03BN/AN/A0.0%N/A0.0%0.00%
    Abivax SA American Depositary Shares (ABVX)$7.67BN/AN/A0.0%-159.6%-6.8%0.00%
    Immunovant Inc (IMVT)$7.07BN/AN/A0.0%N/A0.0%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Immunitybio Inc (IBRX)$6.40BN/A30.3x0.0%-780.5%52.3%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    CG Oncology, Inc. Common stock (CGON)$6.65BN/AN/A0.0%-21.1%-3.7%0.00%
    Protagonist Therapeutics Inc (PTGX)$8.55B27.7x15.8x62.0%N/A5724.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Axsome Therapeutics Inc (AXSM)$7.45BN/A8.6x-18.2%-48.1%51.9%0.00%
    Exelixis Inc (EXEL)$16.84B19.3x6.9x35.4%N/A10.2%0.00%
    Peer median$8.18B34.1x15.8x0.0%-57.0%20.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Vaxcyte, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Abivax SA American Depositary Shares (ABVX)
    Abivax SA is a clinical-stage biotechnology firm focused on pioneering immunotherapies for chronic inflammatory diseases and viral infections.
    ABVX competitors
    Immunovant Inc (IMVT)
    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
    IMVT competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Immunitybio Inc (IBRX)
    ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose...
    IBRX competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    CG Oncology, Inc. Common stock (CGON)
    CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070...
    CGON competitors
    Protagonist Therapeutics Inc (PTGX)
    Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical...
    PTGX competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Axsome Therapeutics Inc (AXSM)
    Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United...
    AXSM competitors
    Exelixis Inc (EXEL)
    Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development...
    EXEL competitors

    Frequently Asked Questions About PCVX

    Who are Vaxcyte's main competitors?

    The companies most similar to Vaxcyte include Abivax SA American Depositary Shares (ABVX), Immunovant (IMVT), Cytokinetics (CYTK), TG Therapeutics (TGTX) and Immunitybio (IBRX), listed from the closest match.

    Who is Vaxcyte's biggest competitor?

    Exelixis (EXEL) is the largest of the similar companies at $16.84B; Abivax SA American Depositary Shares (ABVX) is the closest match by business profile, size, sector and industry.

    How does PCVX stock compare with its competitors?

    PCVX's net margin is 0.0% against a peer median of 0.0%.

    Which of Vaxcyte's competitors pays a higher dividend?

    Vaxcyte pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Vaxcyte bigger than its competitors?

    No. Vaxcyte is 3rd by market cap among the 13 companies on this page; the largest is Exelixis (EXEL) at $16.84B.